A coronavirus vaccine developed by the University of Oxford indicates no early safety concerns and induces strong immune responses in both parts of the immune system, said reports. Trials involving 1,077 people showed the injection led to them making antibodies and T-cells that can fight coronavirus. The results of the Phase I/II trial published today in the scientific journal, The Lancet, said the vaccine provoked a T cell response within ...